Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs

Por Quiros, Steve, Roos, Wynand Paul, Kaina, Bernd
Publicado em 2011

Bactericidal and Antiendotoxic Properties of Short Cationic Peptides Derived from a Snake Venom Lys49 Phospholipase A(2)

Por Santamaría, Carlos, Larios, Silda, Quirós, Steve, Pizarro-Cerda, Javier, Gorvel, Jean-Pierre, Lomonte, Bruno, Moreno, Edgardo
Publicado em 2005

Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage

Por Knizhnik, Anna V., Roos, Wynand P., Nikolova, Teodora, Quiros, Steve, Tomaszowski, Karl-Heinz, Christmann, Markus, Kaina, Bernd
Publicado em 2013

B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells

Por Roos, Wynand P., Quiros, Steve, Krumm, Andrea, Merz, Stephanie, Switzeny, Olivier Jérôme, Christmann, Markus, Loquai, Carmen, Kaina, Bernd
Publicado no Oncotarget (2014)